Operating Income (Loss) in USD of Verona Pharma plc from 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Verona Pharma plc quarterly/annual Operating Income (Loss) history and change rate from 2019 to Q2 2025.
  • Verona Pharma plc Operating Income (Loss) for the quarter ending 30 Jun 2025 was $13.3M.
  • Verona Pharma plc Operating Income (Loss) for the twelve months ending 30 Jun 2025 was -$56M, a 57.2% increase year-over-year.
  • Verona Pharma plc annual Operating Income (Loss) for 2024 was -$155M, a 129% decline from 2023.
  • Verona Pharma plc annual Operating Income (Loss) for 2023 was -$67.6M, a 10.8% increase from 2022.
  • Verona Pharma plc annual Operating Income (Loss) for 2022 was -$75.8M, a 3.32% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Verona Pharma plc Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$56M $13.3M +$81.7M 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 -$138M -$10.3M +$16.9M +62.1% 01 Jan 2025 31 Mar 2025 10-Q 29 Apr 2025
Q4 2024 -$155M -$18.3M +$755K +3.95% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2025
Q3 2024 -$155M -$40.7M -$24.4M -149% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2024
Q2 2024 -$131M -$68.4M -$58.5M -587% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025
Q1 2024 -$72.6M -$27.2M -$5M -22.5% 01 Jan 2024 31 Mar 2024 10-Q 29 Apr 2025
Q4 2023 -$67.6M -$19.1M -$4.05M -26.9% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2025
Q3 2023 -$63.5M -$16.3M -$1.18M -7.82% 01 Jul 2023 30 Sep 2023 10-Q 04 Nov 2024
Q2 2023 -$62.3M -$9.97M +$10.5M +51.4% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$72.9M -$22.2M +$2.87M +11.4% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024
Q4 2022 -$75.8M -$15M +$13.4M +47.1% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025
Q3 2022 -$89.2M -$15.1M -$21.7M -331% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023
Q2 2022 -$67.5M -$20.5M +$8.04M +28.2% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023
Q1 2022 -$75.5M -$25.1M -$2.21M -9.67% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 -$73.3M -$28.5M -$760K -2.74% 01 Oct 2021 31 Dec 2021 10-K 07 Mar 2023
Q3 2021 -$72.6M $6.56M +$27.7M 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 -$100M -$28.5M -$17.6M -160% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 -$82.6M -$22.9M -$8.37M -57.8% 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022
Q4 2020 -$74.3M -$27.7M 01 Oct 2020 31 Dec 2020 10-K 03 Mar 2022
Q3 2020 -$21.1M 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 -$11M 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021
Q1 2020 -$14.5M 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021

Verona Pharma plc Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$155M -$87.1M -129% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025
2023 -$67.6M +$8.18M +10.8% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025
2022 -$75.8M -$2.44M -3.32% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025
2021 -$73.3M +$964K +1.3% 01 Jan 2021 31 Dec 2021 10-K 07 Mar 2023
2020 -$74.3M -$21.9M -41.7% 01 Jan 2020 31 Dec 2020 10-K 03 Mar 2022
2019 -$52.4M 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.